NEW YORK (GenomeWeb News) – Prodesse will distribute Cepheid’s SmartCycler System and related products in the US under a new non-exclusive agreement, Milwaukee, Wis.-based Prodesse said today.

Prodesse’s ProFlu+ Assay and three other assays have been cleared by the Food and Drug Administration for use with the SmartCycler, and other tests are in the pipeline, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.